908 Devices reports Q2 revenue $11.1M (+34% YoY), reiterates FY22 guidance; acquires TRACE Analytics

908 Devices Inc.

2022-Q2 EPS reported -$0.56 revenue$19,412,000

Q2 revenue $11.1M, up 34% YoY; gross margin 60% vs 53% prior year.
Net loss $8.1M ($0.26 loss per share) vs $7.4M ($0.27) prior year.
Installed base 2,142 devices; placed 124 devices in Q2.
FY2022 revenue guidance reaffirmed at $52M-$55M (23%-30% growth).
Acquired TRACE Analytics, an online bioreactor sampling and biosensor technology provider.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.